GlassScriptPhysician profile
Todd M Holt
NPI 1922009687
$3,409.97
in general payments reported to CMS, 2019-2025
33 companies · $174 in 2025
The $174 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $544 · 2020: $318 · 2021: $442 · 2022: $874 · 2023: $498 · 2024: $560 · 2025: $174.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,232.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,231.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $514.19 | 2019-2025 | |
| Sumitomo Pharma America, INC. | $362.67 | 2023-2025 | Myfembree |
| Myovant Sciences INC. | $344.83 | 2021-2022 | |
| Evofem Biosciences, INC. | $244.34 | 2020-2025 | Phexxi, Solosec, Phexx |
| Pfizer INC. | $242.34 | 2019-2024 | |
| Organon LLC | $218.57 | 2022-2025 | Nexplanon |
| Mayne Pharma Commercial LLC | $183.22 | 2021-2025 | |
| Avion Pharmaceuticals | $121.66 | 2020-2023 | Divigel |
| Astellas Pharma US INC | $116.42 | 2021-2025 | Veozah |
| Ethicon US, LLC | $110.33 | 2019-2024 | Stratafix, Ethicon, Evarrest |
| Bayer Healthcare Pharmaceuticals INC. | $102.51 | 2019-2023 | |
| Lupin INC. | $91.19 | 2019-2021 | |
| Therapeuticsmd, INC. | $82.09 | 2019-2022 | |
| Hologic Sales and Service, LLC | $81.93 | 2019-2024 | Thinprep 2000 Processor, Aptima |
| Amag Pharmaceuticals, INC. | $71.08 | 2019 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mylan Pharmaceuticals INC. | $67.43 | 2019-2022 | |
| Agile Therapeutics, INC. | $61.22 | 2021-2024 | Twirla |
| Allergan, INC. | $58.09 | 2019 | |
| Vertical Pharmaceuticals, LLC | $42.15 | 2019 | |
| Exact Sciences Corporation | $31.12 | 2023-2024 | Cologuard Collection Kit |
| Coopersurgical, INC. | $29.98 | 2020-2021 | |
| Meditrina | $27.91 | 2024 | |
| Covidien LP | $27.51 | 2019 | |
| Merck Sharp & Dohme LLC | $27.02 | 2021-2022 | |
| Davol INC. | $25.63 | 2022 | |
| Duchesnay USA Incorporated | $23.82 | 2019 | |
| Millicent US INC | $19.35 | 2023 | Femring, Intrarosa |
| Medicem INC. | $18.00 | 2020 | |
| Exeltis, USA INC. | $15.12 | 2025 | Slynd |
| Biohaven Pharmaceutical Holding Company LTD. | $13.43 | 2022 | |
| Ascend Therapeutics US, LLC | $13.20 | 2019 | |
| Minerva Surgical, INC | $10.88 | 2019 | |
| Biom'Up Sa | $10.74 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Todd Holt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.